Ceribell is a fast-growing venture-backed medical device start-up company that was founded in 2014 by Heath Lukatch, Susan Jacobs, and Serena Joshi, faculty members at Stanford University. The company's primary mission is to improve neurological care for emergency and ICU patients by making EEG more accessible, efficient, and cost-effective. Ceribell offers innovative solutions for diagnosing and treating patients at risk for seizures, with a focus on providing 24/7 continuous bedside EEG monitoring and alerts. With a culture that values innovation, dynamic growth, and technological advancements, Ceribell is at the forefront of revolutionizing neurodiagnostics in the medical industry.

- Ceribell is a leading provider of point-of-care EEG solutions - The company is revolutionizing neurodiagnostics with AI-powered technologies - Ceribell is committed to enhancing critical care practices with rapid EEG monitoring